Zhao Hong, Halicka H Dorota, Li Jiangwei, Darzynkiewicz Zbigniew
Brander Cancer Research Institute and Department of Pathology, New York Medical College, Valhalla, NY 10595, USA.
Aging (Albany NY). 2013 Aug;5(8):623-36. doi: 10.18632/aging.100593.
Berberine (BRB), a natural alkaloid, has a long history of medicinal use in both Ayurvedic and old Chinese medicine. Recently, available as a dietary supplement, Berberine is reported to have application in treatment of variety diseases. Previously we observed that BRB inhibited mTOR/S6 signaling concurrently with reduction of the level of endogenous oxidants and constitutive DNA damage response. We currently tested whether Berberine can affect premature, stress-induced cellular senescence caused by mitoxantrone. The depth of senescence was quantitatively measured by morphometric parameters, senescence-associated β-galactosidase, induction of p21WAF1, replication stress (γH2AX expression), and mTOR signaling; the latter revealed by ribosomal S6 protein (rpS6) phosphorylation. All these markers of senescence were distinctly diminished, in a concentration-dependent manner, by Berberine. In view of the evidence that BRB localizes in mitochondria, inhibits respiratory electron chain and activates AMPK, the observed attenuation of the replication stress-induced cellular senescence most likely is mediated by AMPK that leads to inhibition of mTOR signaling. In support of this mechanism is the observation that rhodamine123, the cationic probe targeting mitochondrial electron chain, also suppressed rpS6 phosphorylation. The present findings reveal that: (a) in cells induced to senescence BRB exhibits gero-suppressive properties by means of mTOR/S6 inhibition; (b) in parallel, BRB reduces the level of constitutive DNA damage response, previously shown to report oxidative DNA damage by endogenous ROS; (c) there appears to a causal linkage between the (a) and (b) activities; (d) the in vitro model of premature stress-induced senescence can be used to assess effectiveness of potential gero-suppressive agents targeting mTOR/S6 and ROS signaling; (e) since most of the reported beneficial effects of BRB are in age-relate diseases, it is likely that gero-suppression is the primary activity of this traditional medicine.
黄连素(BRB)是一种天然生物碱,在阿育吠陀医学和中医中都有悠久的药用历史。最近,作为一种膳食补充剂,黄连素被报道可用于治疗多种疾病。此前我们观察到,BRB抑制mTOR/S6信号传导,同时降低内源性氧化剂水平和组成性DNA损伤反应。我们目前测试了黄连素是否能影响由米托蒽醌引起的过早、应激诱导的细胞衰老。通过形态计量学参数、衰老相关β-半乳糖苷酶、p21WAF1的诱导、复制应激(γH2AX表达)和mTOR信号传导来定量测量衰老深度;后者通过核糖体S6蛋白(rpS6)磷酸化来揭示。黄连素以浓度依赖的方式使所有这些衰老标志物明显减少。鉴于有证据表明BRB定位于线粒体,抑制呼吸电子链并激活AMPK,观察到的复制应激诱导的细胞衰老的减弱很可能是由AMPK介导的,AMPK导致mTOR信号传导的抑制。支持这一机制的观察结果是,靶向线粒体电子链的阳离子探针罗丹明123也抑制了rpS6磷酸化。目前的研究结果表明:(a)在诱导衰老的细胞中,BRB通过抑制mTOR/S6表现出抗衰老特性;(b)同时,BRB降低了组成性DNA损伤反应的水平,此前已证明该反应可报告内源性ROS引起的氧化性DNA损伤;(c)(a)和(b)的活性之间似乎存在因果联系;(d)过早应激诱导的衰老的体外模型可用于评估靶向mTOR/S6和ROS信号传导的潜在抗衰老剂的有效性;(e)由于BRB报道的大多数有益作用都在与年龄相关的疾病中,因此抗衰老很可能是这种传统药物的主要活性。